Christopher Haqq Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Haqq.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Haqq. Christopher Haqq is Chief Medical Officer in Atara Biotherapeutics, Inc. ($ATRA) and EVP, R&D & Chief Scientific Of in Atara Biotherapeutics, Inc. ($ATRA).
Latest Insider Trading Transactions of Christopher Haqq
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2019 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 38.55 | 13,975 | 538,736 | 272,718 | 286.7 K to 272.7 K (-4.87 %) |
| Nov 15 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 33.81 | 775 | 26,203 | 285,580 | 286.4 K to 285.6 K (-0.27 %) |
| Sep 27 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 43.08 | 13,500 | 581,580 | 286,355 | 299.9 K to 286.4 K (-4.50 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 41.23 | 3,500 | 144,305 | 299,855 | 303.4 K to 299.9 K (-1.15 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 40.26 | 10,000 | 402,600 | 303,355 | 313.4 K to 303.4 K (-3.19 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 40.53 | 3,931 | 159,323 | 313,355 | 317.3 K to 313.4 K (-1.24 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 39.74 | 14,069 | 559,102 | 317,286 | 331.4 K to 317.3 K (-4.25 %) |
| Aug 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 37.54 | 775 | 29,094 | 331,355 | 332.1 K to 331.4 K (-0.23 %) |
| May 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 11.00 | 25,000 | 275,000 | 25,000 | |
| May 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 46.02 | 9,252 | 425,777 | 332,130 | 341.4 K to 332.1 K (-2.71 %) |
| May 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 45.21 | 9,638 | 435,734 | 341,382 | 351 K to 341.4 K (-2.75 %) |
| May 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 44.44 | 6,885 | 305,969 | 351,020 | 357.9 K to 351 K (-1.92 %) |
| May 16 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 11.00 | 25,000 | 275,000 | 357,905 | 332.9 K to 357.9 K (+7.51 %) |
| Mar 27 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 40.29 | 1,100 | 44,319 | 332,905 | 334 K to 332.9 K (-0.33 %) |
| Mar 27 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 39.76 | 17,227 | 684,946 | 334,005 | 351.2 K to 334 K (-4.90 %) |
| Feb 20 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 0.00 | 553 | 0 | 0 | |
| Feb 20 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 0.00 | 553 | 0 | 351,232 | 350.7 K to 351.2 K (+0.16 %) |
| Feb 12 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Payment of Exercise | F | 41.70 | 4,925 | 205,373 | 350,679 | 355.6 K to 350.7 K (-1.38 %) |
| Feb 08 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | A | 35.80 | 35,000 | 1,253,000 | 35,000 | |
| Feb 08 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Payment of Exercise | F | 35.80 | 4,426 | 158,451 | 355,604 | 360 K to 355.6 K (-1.23 %) |
| Feb 08 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Grant | A | 0.00 | 17,500 | 0 | 360,030 | 342.5 K to 360 K (+5.11 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 0.00 | 829 | 0 | 553 | |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 13.36 | 1,604 | 21,429 | 342,530 | 344.1 K to 342.5 K (-0.47 %) |
| Nov 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 0.00 | 829 | 0 | 344,134 | 343.3 K to 344.1 K (+0.24 %) |
| Oct 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 14.35 | 6,000 | 86,100 | 343,305 | 349.3 K to 343.3 K (-1.72 %) |
| Sep 18 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 15.30 | 6,000 | 91,800 | 349,305 | 355.3 K to 349.3 K (-1.69 %) |
| Aug 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 0.00 | 829 | 0 | 1,382 | |
| Aug 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 14.75 | 7,604 | 112,159 | 355,305 | 362.9 K to 355.3 K (-2.10 %) |
| Aug 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 0.00 | 829 | 0 | 362,909 | 362.1 K to 362.9 K (+0.23 %) |
| Jul 18 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 14.92 | 6,000 | 89,520 | 362,080 | 368.1 K to 362.1 K (-1.63 %) |
| Jun 16 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 12.65 | 6,000 | 75,900 | 368,080 | 374.1 K to 368.1 K (-1.60 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 0.00 | 829 | 0 | 2,211 | |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 14.99 | 7,604 | 113,984 | 374,080 | 381.7 K to 374.1 K (-1.99 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 0.00 | 829 | 0 | 381,684 | 380.9 K to 381.7 K (+0.22 %) |
| Apr 19 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 17.28 | 6,000 | 103,680 | 380,855 | 386.9 K to 380.9 K (-1.55 %) |
| Mar 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 19.60 | 6,000 | 117,600 | 386,855 | 392.9 K to 386.9 K (-1.53 %) |
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 0.00 | 829 | 0 | 3,040 | |
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 15.49 | 7,604 | 117,786 | 392,855 | 400.5 K to 392.9 K (-1.90 %) |
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 0.00 | 829 | 0 | 400,459 | 399.6 K to 400.5 K (+0.21 %) |
| Feb 10 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 15.46 | 13,975 | 216,054 | 399,630 | 413.6 K to 399.6 K (-3.38 %) |
| Feb 08 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Grant | A | 0.00 | 49,500 | 0 | 413,605 | 364.1 K to 413.6 K (+13.59 %) |
| Jan 18 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 14.27 | 6,000 | 85,620 | 364,105 | 370.1 K to 364.1 K (-1.62 %) |
| Dec 15 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 15.40 | 6,000 | 92,400 | 370,105 | 376.1 K to 370.1 K (-1.60 %) |
| Nov 22 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 17.85 | 7,068 | 126,164 | 376,105 | 383.2 K to 376.1 K (-1.84 %) |
| Nov 17 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 829 | 0 | 3,869 | |
| Nov 17 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 19.95 | 1,604 | 32,000 | 383,173 | 384.8 K to 383.2 K (-0.42 %) |
| Nov 17 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 829 | 0 | 384,777 | 383.9 K to 384.8 K (+0.22 %) |
| Sep 23 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Grant | A | 0.00 | 90,000 | 0 | 383,948 | 293.9 K to 383.9 K (+30.62 %) |
| Aug 17 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 829 | 0 | 4,698 | |
| Aug 17 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 22.58 | 946 | 21,361 | 293,948 | 294.9 K to 293.9 K (-0.32 %) |
| Aug 17 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 21.70 | 400 | 8,680 | 294,894 | 295.3 K to 294.9 K (-0.14 %) |
| Aug 17 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 829 | 0 | 295,294 | 294.5 K to 295.3 K (+0.28 %) |
| May 18 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 830 | 0 | 5,527 | |
| May 18 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 15.57 | 1,605 | 24,990 | 294,465 | 296.1 K to 294.5 K (-0.54 %) |
| May 18 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 830 | 0 | 296,070 | 295.2 K to 296.1 K (+0.28 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 829 | 0 | 6,357 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 15.43 | 3,208 | 49,499 | 295,240 | 298.4 K to 295.2 K (-1.07 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 829 | 0 | 298,448 | 297.6 K to 298.4 K (+0.28 %) |
| Feb 11 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Grant | A | 0.00 | 55,900 | 0 | 297,619 | 241.7 K to 297.6 K (+23.13 %) |
| Dec 21 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Option Exercise | A | 22.72 | 75,000 | 1,704,000 | 75,000 | |
| Nov 18 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 829 | 0 | 7,186 | |
| Nov 18 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 829 | 0 | 241,719 | 240.9 K to 241.7 K (+0.34 %) |
| Sep 01 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 42.10 | 3,900 | 164,190 | 240,890 | 244.8 K to 240.9 K (-1.59 %) |
| Sep 01 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 41.61 | 1,100 | 45,771 | 244,790 | 245.9 K to 244.8 K (-0.45 %) |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 829 | 0 | 8,015 | |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 46.58 | 300 | 13,974 | 245,890 | 246.2 K to 245.9 K (-0.12 %) |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 45.75 | 1,304 | 59,658 | 246,190 | 247.5 K to 246.2 K (-0.53 %) |
| Aug 19 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 829 | 0 | 247,494 | 246.7 K to 247.5 K (+0.34 %) |
| Aug 03 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 55.43 | 2,500 | 138,575 | 246,665 | 249.2 K to 246.7 K (-1.00 %) |
| Jul 15 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 63.39 | 800 | 50,712 | 249,165 | 250 K to 249.2 K (-0.32 %) |
| Jul 15 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 62.73 | 1,700 | 106,641 | 249,965 | 251.7 K to 250 K (-0.68 %) |
| Jul 02 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 52.36 | 1,300 | 68,068 | 251,665 | 253 K to 251.7 K (-0.51 %) |
| Jul 02 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 50.94 | 1,200 | 61,128 | 252,965 | 254.2 K to 253 K (-0.47 %) |
| Jun 16 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 47.34 | 1,100 | 52,074 | 254,165 | 255.3 K to 254.2 K (-0.43 %) |
| Jun 16 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 46.34 | 6,100 | 282,674 | 255,265 | 261.4 K to 255.3 K (-2.33 %) |
| Jun 16 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 44.56 | 300 | 13,368 | 261,365 | 261.7 K to 261.4 K (-0.11 %) |
| Jun 01 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 42.68 | 450 | 19,206 | 261,665 | 262.1 K to 261.7 K (-0.17 %) |
| Jun 01 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 41.68 | 700 | 29,176 | 262,115 | 262.8 K to 262.1 K (-0.27 %) |
| Jun 01 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 40.95 | 1,350 | 55,283 | 262,815 | 264.2 K to 262.8 K (-0.51 %) |
| May 19 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 4,422 | 0 | 8,844 | |
| May 19 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Payment of Exercise | F | 37.30 | 1,887 | 70,385 | 264,165 | 266.1 K to 264.2 K (-0.71 %) |
| May 19 2015 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 4,422 | 0 | 266,052 | 261.6 K to 266.1 K (+1.69 %) |
| Oct 23 2014 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Option Exercise | A | 0.00 | 13,266 | 0 | 13,266 | |
| Oct 16 2014 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Option Exercise | M | 11.00 | 50,000 | 550,000 | 50,000 |
Page: 1